Bosutinib Discount Agreements
Original notice title
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Bosutinib, ATC L01EA04
Opportunity Score
Why this score?
Opportunity
40 / 100
Complexity
20 / 100
Risk factors
No guaranteed sales volume; discounts are purely contractual without minimum purchase obligations.
Agreements automatically terminate if a competitive discount agreement for Bosutinib is concluded at national or region...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- Framework procurement
- Supplies contract
- 1 lot
- Duration until Nov 2026
- Non-exclusive discount agreements for Bosutinib (ATC L01EA04) pharmaceutical products
- All interested pharmaceutical companies can join
Show full summary
The AOK Bayern is conducting an open-house model (not a competitive tender) to enter into non-exclusive discount agreements with all interested pharmaceutical companies for the active substance Bosutinib (ATC L01EA04) under § 130a Abs. 8 SGB V. The contract runs from 01.12.2024 to 30.11.2026, with the possibility of joining any time until 05.10.2026. No estimated value is provided. The procedure is outside procurement law; agreements are identical and non-negotiable. Eligibility is solely demonstrated via a signed self-declaration of reliability.
Risks
No guaranteed sales volume; discounts are purely contractual without minimum purchase obligations.
Agreements automatically terminate if a competitive discount agreement for Bosutinib is concluded at national or region...
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Must be a pharmaceutical company (pharmazeutischer Unternehmer)
Administrative
- Submit signed self-declaration of reliability (Eigenerklärung zur Zuverlässigkeit)
- Submit signed contract and annex 'Festlegung der vertragsgegenständlichen Arzneimittel'
Requirements may be incomplete.
Award Criteria
Lot 1
Buyer
Location
München, DEU
Website
Buyer profile
Identifier
DE811695320
Activity
Health
Lots (1)
LOT-0001
Bosutinib Discount Agreements
Non-exclusive discount agreements for pharmaceutical products containing Bosutinib (ATC L01EA04). All interested pharmaceutical companies meeting eligibility can join. Contracts identical, not negotiable. Early start 01.12.2024, end 30.11.2026.
Location
Duration
Category
Award Criteria
Deadline
Award details
No award criteria
this is an open-house model with no selection decision.
Value note
Show original TED data
Original lot title
Open house Arzneimittelrabattverträge Bosutinib, ATC L01EA04
Original TED description
Siehe kurze Beschreibung
Procurement Details
- Publication date
- 16 Oct 2024
- Languages
- German
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 628220-2024
Documents (2)
Similar tenders
France – Insurance services – Prestations de services d'assurance pour groupement le groupement hospitalier de territoire Yvelines Nord
Finland – Architectural, construction, engineering and inspection services – Tietomallikoordinaattori-, inventointimittaus- ja mallinnuspalvelujen puitejärjestely 2026-2028 (2028-2030)
Romania – Street-cleaning and sweeping services – Acord cadru de prestare a serviciilor de delegare a activităților de măturat, spălat, stropit si întreținerea căilor publice și activități de curățare și transport al zăpezii de pe căile publice și menținerea în funcțiune a acestora pe timp de polei sau îngheț, pe timp de iarnă din cadrul serviciului de salubrizare a orașului Negrești Oaș
France – Insurance services – MARCHE DE SERVICES EN ASSURANCE
Spain – Building-cleaning services – Servicios de limpieza en Centros de Sevilla, Murcia y Galicia, de la Agencia Estatal Consejo Superior de Investigaciones Científicas.
Spain – Architectural, construction, engineering and inspection services – Redacción del Proyecto Básico y de Ejecución, Redacción del Estudio de Seguridad y Salud y Dirección de Obra para la construcción del I.E.S. Nº 1 de 12+0 uds. (Fase 1) en la urbanización El Bosque de Pioz (Guadalajara).
Opportunity Score
Why this score?
Opportunity
40 / 100
Complexity
20 / 100
Risk factors
No guaranteed sales volume; discounts are purely contractual without minimum purchase obligations.
Agreements automatically terminate if a competitive discount agreement for Bosutinib is concluded at national or region...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications